Skip to main content

Table 2 Undergoing immunosuppressive therapy at enrollment

From: First clinical application of cord blood mesenchymal stromal cells in children with multi-drug resistant nephrotic syndrome

Patient

Therapy

Patient #1

PDN, CsA

Patient #3

PDN, CsA, MMF

Patient #5

CsA

Patient #6

TAC, MMF

Patient #7

PDN, CsA, MMF

Patient #8

TAC

Patient #9

PDN, CsA, MMF

Patient #10

TAC

Patient #11

PDN

  1. PDN prednisone, CsA cyclosporine-A, MMF mycophenolate mofetil, TAC tacrolimus